Plain-English translation of NCT06555523 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using ultrasound imaging to guide trigger point injections works better than injecting without imaging for fibromyalgia pain. Trigger point injections deliver a numbing medication called lidocaine directly into tight, painful muscle areas, especially in the neck and shoulders. The study wants to see if ultrasound guidance makes these injections more effective and safer.
Fibromyalgia causes widespread muscle pain and tenderness that can be very difficult to treat. While trigger point injections are a known pain-relief method, doctors aren't sure whether using ultrasound to guide the needle improves results or reduces complications compared to the traditional method of feeling for the tender spot by hand.
You likely qualify if…
You likely don't qualify if…
You will receive one trigger point injection in your neck/shoulder muscles (either guided by ultrasound or without it, depending on which group you're assigned to). You'll receive the same numbing medication in both cases. After the injection, you will be given home exercises to do—stretches and posture exercises for your neck and chest—for one month. One month after your injection, you'll return for an assessment where doctors will ask you questions and measure your pain, function, anxiety, and neck disability to see how much the treatment helped.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Turkey (Türkiye)